SEC Form 4 · accession 0001123292-19-000231
PRECIGEN, INC. · PGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas D. Reed
Officer — Chief Science Officer
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 4:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356090
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2019 | M | 2,969 | $3.17 | A | 96,280 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock (Right to Buy)F1 | $3.17 | Feb 7, 2019 | M | 2,969 | D | — | Feb 20, 2019 | Common Stock | 2,969 | 0 | D |
Explanation of responses
- F1The option was immediately exercisable.